[refurb]

"Likewise, if you’re a pharmaceutical executive, one way to create profits is to generate new products. Another is to lobby Congress to bar the government’s Medicare program from bargaining for drug prices. That amounts to a $50 billion annual gift to pharmaceutical companies."

This "fact" always annoys me. Yes, Medicare can't directly negotiate with drug companies. However, there are two mechanisms that provide substantial discounts for drugs that Medicare buys.

1. All drug manufacturers must report the price they sell their drugs for to the government every quarter. That data is used to create the ASP (average selling price). This is the price Medicare pays. If a drug company starts offering discounts on their sales to private insurers, that get added to the ASP.

2. For drugs covered under Medicare Part D (pharmacy benefits), there is something called the "donut hole" where a patient has to pay the full costs of the drug. That is being phased out by 2020. Drug companies will have to pay for the donut hole themselves. The discount varies with the drug price, but for example, if a drug costs $5000 in a year, drug companies will have to pay $1300 of that back to the government.

So yes, Medicare doesn't directly negotiate with drug companies, rather they legislate big discounts.